Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Blount

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2018
Reply to Million et alErik R Dubberke, Ken Blount, Dale N Gerding
Frontiers in Microbiology|January 21, 2022
Development and Validation of a Novel Microbiome-Based Biomarker of Post-antibiotic Dysbiosis and Subsequent RestorationKen Blount, Courtney Jones, Dana Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2020
RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile InfectionsSahil Khanna, Darrell S Pardi, Courtney Jones, et al.
Microorganisms|January 21, 2023
Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent <i>Clostridioides difficile</i> InfectionRomeo Papazyan, Nicky Ferdyan, Karthik Srinivasan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2018
Reply to Million et alErik R Dubberke, Ken Blount, Dale N Gerding
Frontiers in Microbiology|January 21, 2022
Development and Validation of a Novel Microbiome-Based Biomarker of Post-antibiotic Dysbiosis and Subsequent RestorationKen Blount, Courtney Jones, Dana Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2020
RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile InfectionsSahil Khanna, Darrell S Pardi, Courtney Jones, et al.
Microorganisms|January 21, 2023
Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent <i>Clostridioides difficile</i> InfectionRomeo Papazyan, Nicky Ferdyan, Karthik Srinivasan, et al.
Pageof 1